<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(1)</volume><submitter>Liu A</submitter><funding>Joint Funds for the Innovation of Science and Technology, Fujian Province</funding><funding>Horizontal Project of the Second Affiliated Hospital of Fujian Medical University</funding><journal>Journal of neuroinflammation</journal><pagination>68</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12911015</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Esketamine alleviates COPD-depression comorbidity in rats via MAPK/NF-κB inhibition and gut-lung-brain axis modulation.</pubmed_title><pmcid>PMC12911015</pmcid><funding_grant_id>2025004HX</funding_grant_id><funding_grant_id>2025Y9369</funding_grant_id><pubmed_authors>Guo JX</pubmed_authors><pubmed_authors>Li CY</pubmed_authors><pubmed_authors>Zhang XQ</pubmed_authors><pubmed_authors>Liu A</pubmed_authors><pubmed_authors>Chen ZY</pubmed_authors><pubmed_authors>Zheng WJ</pubmed_authors><pubmed_authors>Dai K</pubmed_authors><pubmed_authors>Wen QY</pubmed_authors><pubmed_authors>Wu JH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Esketamine alleviates COPD-depression comorbidity in rats via MAPK/NF-κB inhibition and gut-lung-brain axis modulation.</name><description/><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-09T13:10:57.728Z</modification><creation>2026-07-09T13:09:41.582Z</creation></dates><accession>S-EPMC12911015</accession><cross_references><pubmed>41572340</pubmed><doi>10.1186/s12974-026-03699-1</doi></cross_references></HashMap>